nodes	percent_of_prediction	percent_of_DWPC	metapath
Isoniazid—CYP2A6—Prednisolone—psoriatic arthritis	0.17	0.22	CbGbCtD
Isoniazid—CYP2A6—Dexamethasone—psoriatic arthritis	0.1	0.13	CbGbCtD
Isoniazid—CYP2C19—Prednisone—psoriatic arthritis	0.0664	0.0859	CbGbCtD
Isoniazid—CYP2E1—Dexamethasone—psoriatic arthritis	0.0661	0.0855	CbGbCtD
Isoniazid—CYP3A4—Methylprednisolone—psoriatic arthritis	0.053	0.0685	CbGbCtD
Isoniazid—CYP2C8—Dexamethasone—psoriatic arthritis	0.0494	0.0639	CbGbCtD
Isoniazid—CYP2C19—Dexamethasone—psoriatic arthritis	0.0415	0.0536	CbGbCtD
Isoniazid—CYP3A4—Triamcinolone—psoriatic arthritis	0.0402	0.0519	CbGbCtD
Isoniazid—CYP2C9—Dexamethasone—psoriatic arthritis	0.0345	0.0446	CbGbCtD
Isoniazid—CYP3A4—Betamethasone—psoriatic arthritis	0.0345	0.0446	CbGbCtD
Isoniazid—CYP3A4—Prednisolone—psoriatic arthritis	0.034	0.044	CbGbCtD
Isoniazid—CYP3A4—Prednisone—psoriatic arthritis	0.0321	0.0415	CbGbCtD
Isoniazid—CYP2D6—Dexamethasone—psoriatic arthritis	0.0315	0.0408	CbGbCtD
Isoniazid—CYP3A4—Dexamethasone—psoriatic arthritis	0.02	0.0259	CbGbCtD
Isoniazid—Atrophy—Prednisolone—psoriatic arthritis	0.00613	0.027	CcSEcCtD
Isoniazid—Aplastic anaemia—Auranofin—psoriatic arthritis	0.00588	0.0259	CcSEcCtD
Isoniazid—Atrophy—Triamcinolone—psoriatic arthritis	0.00564	0.0249	CcSEcCtD
Isoniazid—Atrophy—Methylprednisolone—psoriatic arthritis	0.00562	0.0248	CcSEcCtD
Isoniazid—Diabetic—Methylprednisolone—psoriatic arthritis	0.00549	0.0242	CcSEcCtD
Isoniazid—Atrophy—Betamethasone—psoriatic arthritis	0.00511	0.0226	CcSEcCtD
Isoniazid—Atrophy—Dexamethasone—psoriatic arthritis	0.00511	0.0226	CcSEcCtD
Isoniazid—Diabetic—Dexamethasone—psoriatic arthritis	0.00499	0.022	CcSEcCtD
Isoniazid—Diabetic—Betamethasone—psoriatic arthritis	0.00499	0.022	CcSEcCtD
Isoniazid—Metabolic acidosis—Methylprednisolone—psoriatic arthritis	0.00464	0.0205	CcSEcCtD
Isoniazid—Atrophy—Prednisone—psoriatic arthritis	0.00445	0.0196	CcSEcCtD
Isoniazid—Eosinophilia—Auranofin—psoriatic arthritis	0.00389	0.0172	CcSEcCtD
Isoniazid—Reaction gastrointestinal—Methotrexate—psoriatic arthritis	0.00363	0.016	CcSEcCtD
Isoniazid—Diabetic—Methotrexate—psoriatic arthritis	0.00363	0.016	CcSEcCtD
Isoniazid—Neuropathy peripheral—Auranofin—psoriatic arthritis	0.00344	0.0152	CcSEcCtD
Isoniazid—Jaundice—Auranofin—psoriatic arthritis	0.00342	0.0151	CcSEcCtD
Isoniazid—Systemic lupus erythematosus—Triamcinolone—psoriatic arthritis	0.00332	0.0146	CcSEcCtD
Isoniazid—Agranulocytosis—Auranofin—psoriatic arthritis	0.00327	0.0144	CcSEcCtD
Isoniazid—Optic neuritis—Prednisolone—psoriatic arthritis	0.00325	0.0143	CcSEcCtD
Isoniazid—Neurotoxicity—Methotrexate—psoriatic arthritis	0.00313	0.0138	CcSEcCtD
Isoniazid—Optic neuritis—Triamcinolone—psoriatic arthritis	0.00299	0.0132	CcSEcCtD
Isoniazid—Optic neuritis—Methylprednisolone—psoriatic arthritis	0.00298	0.0131	CcSEcCtD
Isoniazid—Optic neuritis—Dexamethasone—psoriatic arthritis	0.00271	0.012	CcSEcCtD
Isoniazid—Optic neuritis—Betamethasone—psoriatic arthritis	0.00271	0.012	CcSEcCtD
Isoniazid—Neuritis—Prednisolone—psoriatic arthritis	0.00268	0.0118	CcSEcCtD
Isoniazid—Neuritis—Triamcinolone—psoriatic arthritis	0.00246	0.0109	CcSEcCtD
Isoniazid—Neuritis—Methylprednisolone—psoriatic arthritis	0.00246	0.0108	CcSEcCtD
Isoniazid—Optic neuritis—Prednisone—psoriatic arthritis	0.00236	0.0104	CcSEcCtD
Isoniazid—Neuritis—Betamethasone—psoriatic arthritis	0.00223	0.00985	CcSEcCtD
Isoniazid—Neuritis—Dexamethasone—psoriatic arthritis	0.00223	0.00985	CcSEcCtD
Isoniazid—Thrombocytopenia—Auranofin—psoriatic arthritis	0.00219	0.00965	CcSEcCtD
Isoniazid—Anorexia—Auranofin—psoriatic arthritis	0.00213	0.0094	CcSEcCtD
Isoniazid—Vasculitis—Prednisolone—psoriatic arthritis	0.00205	0.00903	CcSEcCtD
Isoniazid—Eruption—Methotrexate—psoriatic arthritis	0.00197	0.0087	CcSEcCtD
Isoniazid—Dyspepsia—Auranofin—psoriatic arthritis	0.00197	0.00868	CcSEcCtD
Isoniazid—Neuritis—Prednisone—psoriatic arthritis	0.00194	0.00858	CcSEcCtD
Isoniazid—Decreased appetite—Auranofin—psoriatic arthritis	0.00194	0.00857	CcSEcCtD
Isoniazid—Vasculitis—Triamcinolone—psoriatic arthritis	0.00188	0.0083	CcSEcCtD
Isoniazid—Vasculitis—Methylprednisolone—psoriatic arthritis	0.00188	0.00828	CcSEcCtD
Isoniazid—Memory impairment—Prednisone—psoriatic arthritis	0.00185	0.00816	CcSEcCtD
Isoniazid—Vasculitis—Betamethasone—psoriatic arthritis	0.00171	0.00753	CcSEcCtD
Isoniazid—Vasculitis—Dexamethasone—psoriatic arthritis	0.00171	0.00753	CcSEcCtD
Isoniazid—Diabetes mellitus—Prednisolone—psoriatic arthritis	0.00167	0.00735	CcSEcCtD
Isoniazid—Diabetes mellitus—Triamcinolone—psoriatic arthritis	0.00153	0.00676	CcSEcCtD
Isoniazid—Diabetes mellitus—Methylprednisolone—psoriatic arthritis	0.00153	0.00675	CcSEcCtD
Isoniazid—Vasculitis—Prednisone—psoriatic arthritis	0.00149	0.00656	CcSEcCtD
Isoniazid—Vomiting—Auranofin—psoriatic arthritis	0.00142	0.00627	CcSEcCtD
Isoniazid—Rash—Auranofin—psoriatic arthritis	0.00141	0.00622	CcSEcCtD
Isoniazid—Diabetes mellitus—Betamethasone—psoriatic arthritis	0.00139	0.00614	CcSEcCtD
Isoniazid—Diabetes mellitus—Dexamethasone—psoriatic arthritis	0.00139	0.00614	CcSEcCtD
Isoniazid—Hyperbilirubinaemia—Methotrexate—psoriatic arthritis	0.00133	0.00589	CcSEcCtD
Isoniazid—Nausea—Auranofin—psoriatic arthritis	0.00133	0.00586	CcSEcCtD
Isoniazid—Psychotic disorder—Methylprednisolone—psoriatic arthritis	0.0013	0.00573	CcSEcCtD
Isoniazid—Vasculitis—Methotrexate—psoriatic arthritis	0.00124	0.00548	CcSEcCtD
Isoniazid—Diabetes mellitus—Prednisone—psoriatic arthritis	0.00121	0.00534	CcSEcCtD
Isoniazid—Psychotic disorder—Betamethasone—psoriatic arthritis	0.00118	0.00521	CcSEcCtD
Isoniazid—Psychotic disorder—Dexamethasone—psoriatic arthritis	0.00118	0.00521	CcSEcCtD
Isoniazid—Aplastic anaemia—Methotrexate—psoriatic arthritis	0.00114	0.00502	CcSEcCtD
Isoniazid—Neuropathy peripheral—Prednisolone—psoriatic arthritis	0.0011	0.00483	CcSEcCtD
Isoniazid—Gynaecomastia—Methotrexate—psoriatic arthritis	0.00109	0.00479	CcSEcCtD
Isoniazid—Lymphadenopathy—Methotrexate—psoriatic arthritis	0.00103	0.00455	CcSEcCtD
Isoniazid—Psychotic disorder—Prednisone—psoriatic arthritis	0.00103	0.00454	CcSEcCtD
Isoniazid—Diabetes mellitus—Methotrexate—psoriatic arthritis	0.00101	0.00447	CcSEcCtD
Isoniazid—Neuropathy peripheral—Triamcinolone—psoriatic arthritis	0.00101	0.00444	CcSEcCtD
Isoniazid—Neuropathy peripheral—Methylprednisolone—psoriatic arthritis	0.00101	0.00443	CcSEcCtD
Isoniazid—Hyperglycaemia—Betamethasone—psoriatic arthritis	0.000943	0.00416	CcSEcCtD
Isoniazid—Hyperglycaemia—Dexamethasone—psoriatic arthritis	0.000943	0.00416	CcSEcCtD
Isoniazid—Neuropathy peripheral—Betamethasone—psoriatic arthritis	0.000914	0.00403	CcSEcCtD
Isoniazid—Neuropathy peripheral—Dexamethasone—psoriatic arthritis	0.000914	0.00403	CcSEcCtD
Isoniazid—Hyperglycaemia—Prednisone—psoriatic arthritis	0.000822	0.00362	CcSEcCtD
Isoniazid—Ill-defined disorder—Prednisolone—psoriatic arthritis	0.00081	0.00357	CcSEcCtD
Isoniazid—Neuropathy peripheral—Prednisone—psoriatic arthritis	0.000796	0.00351	CcSEcCtD
Isoniazid—Malaise—Prednisolone—psoriatic arthritis	0.000788	0.00347	CcSEcCtD
Isoniazid—Convulsion—Prednisolone—psoriatic arthritis	0.000757	0.00334	CcSEcCtD
Isoniazid—Eosinophilia—Methotrexate—psoriatic arthritis	0.000754	0.00332	CcSEcCtD
Isoniazid—Ill-defined disorder—Triamcinolone—psoriatic arthritis	0.000745	0.00329	CcSEcCtD
Isoniazid—Ill-defined disorder—Methylprednisolone—psoriatic arthritis	0.000744	0.00328	CcSEcCtD
Isoniazid—Discomfort—Prednisolone—psoriatic arthritis	0.000735	0.00324	CcSEcCtD
Isoniazid—Malaise—Triamcinolone—psoriatic arthritis	0.000724	0.00319	CcSEcCtD
Isoniazid—Malaise—Methylprednisolone—psoriatic arthritis	0.000723	0.00319	CcSEcCtD
Isoniazid—Convulsion—Triamcinolone—psoriatic arthritis	0.000696	0.00307	CcSEcCtD
Isoniazid—Convulsion—Methylprednisolone—psoriatic arthritis	0.000694	0.00306	CcSEcCtD
Isoniazid—Ill-defined disorder—Dexamethasone—psoriatic arthritis	0.000676	0.00298	CcSEcCtD
Isoniazid—Ill-defined disorder—Betamethasone—psoriatic arthritis	0.000676	0.00298	CcSEcCtD
Isoniazid—Discomfort—Triamcinolone—psoriatic arthritis	0.000676	0.00298	CcSEcCtD
Isoniazid—Discomfort—Methylprednisolone—psoriatic arthritis	0.000674	0.00297	CcSEcCtD
Isoniazid—Malaise—Dexamethasone—psoriatic arthritis	0.000657	0.0029	CcSEcCtD
Isoniazid—Malaise—Betamethasone—psoriatic arthritis	0.000657	0.0029	CcSEcCtD
Isoniazid—Paraesthesia—Prednisolone—psoriatic arthritis	0.00064	0.00282	CcSEcCtD
Isoniazid—Agranulocytosis—Methotrexate—psoriatic arthritis	0.000633	0.00279	CcSEcCtD
Isoniazid—Convulsion—Betamethasone—psoriatic arthritis	0.000631	0.00279	CcSEcCtD
Isoniazid—Convulsion—Dexamethasone—psoriatic arthritis	0.000631	0.00279	CcSEcCtD
Isoniazid—Discomfort—Betamethasone—psoriatic arthritis	0.000613	0.0027	CcSEcCtD
Isoniazid—Discomfort—Dexamethasone—psoriatic arthritis	0.000613	0.0027	CcSEcCtD
Isoniazid—Hepatitis—Methotrexate—psoriatic arthritis	0.000609	0.00269	CcSEcCtD
Isoniazid—Ill-defined disorder—Prednisone—psoriatic arthritis	0.000589	0.0026	CcSEcCtD
Isoniazid—Paraesthesia—Triamcinolone—psoriatic arthritis	0.000589	0.0026	CcSEcCtD
Isoniazid—Feeling abnormal—Prednisolone—psoriatic arthritis	0.000587	0.00259	CcSEcCtD
Isoniazid—Paraesthesia—Methylprednisolone—psoriatic arthritis	0.000587	0.00259	CcSEcCtD
Isoniazid—Thrombocytopenia—Dexamethasone—psoriatic arthritis	0.000582	0.00257	CcSEcCtD
Isoniazid—Thrombocytopenia—Betamethasone—psoriatic arthritis	0.000582	0.00257	CcSEcCtD
Isoniazid—Dyspepsia—Triamcinolone—psoriatic arthritis	0.000577	0.00255	CcSEcCtD
Isoniazid—Dyspepsia—Methylprednisolone—psoriatic arthritis	0.000576	0.00254	CcSEcCtD
Isoniazid—Malaise—Prednisone—psoriatic arthritis	0.000572	0.00252	CcSEcCtD
Isoniazid—Anorexia—Betamethasone—psoriatic arthritis	0.000567	0.0025	CcSEcCtD
Isoniazid—Anorexia—Dexamethasone—psoriatic arthritis	0.000567	0.0025	CcSEcCtD
Isoniazid—Fatigue—Triamcinolone—psoriatic arthritis	0.000565	0.00249	CcSEcCtD
Isoniazid—Fatigue—Methylprednisolone—psoriatic arthritis	0.000564	0.00249	CcSEcCtD
Isoniazid—Convulsion—Prednisone—psoriatic arthritis	0.00055	0.00243	CcSEcCtD
Isoniazid—Feeling abnormal—Triamcinolone—psoriatic arthritis	0.00054	0.00238	CcSEcCtD
Isoniazid—Feeling abnormal—Methylprednisolone—psoriatic arthritis	0.000539	0.00238	CcSEcCtD
Isoniazid—Paraesthesia—Dexamethasone—psoriatic arthritis	0.000534	0.00236	CcSEcCtD
Isoniazid—Paraesthesia—Betamethasone—psoriatic arthritis	0.000534	0.00236	CcSEcCtD
Isoniazid—Discomfort—Prednisone—psoriatic arthritis	0.000534	0.00235	CcSEcCtD
Isoniazid—Hypersensitivity—Prednisolone—psoriatic arthritis	0.000525	0.00232	CcSEcCtD
Isoniazid—Dyspepsia—Betamethasone—psoriatic arthritis	0.000524	0.00231	CcSEcCtD
Isoniazid—Dyspepsia—Dexamethasone—psoriatic arthritis	0.000524	0.00231	CcSEcCtD
Isoniazid—Body temperature increased—Triamcinolone—psoriatic arthritis	0.000518	0.00229	CcSEcCtD
Isoniazid—Decreased appetite—Dexamethasone—psoriatic arthritis	0.000517	0.00228	CcSEcCtD
Isoniazid—Decreased appetite—Betamethasone—psoriatic arthritis	0.000517	0.00228	CcSEcCtD
Isoniazid—Gastrointestinal disorder—Dexamethasone—psoriatic arthritis	0.000513	0.00226	CcSEcCtD
Isoniazid—Gastrointestinal disorder—Betamethasone—psoriatic arthritis	0.000513	0.00226	CcSEcCtD
Isoniazid—Fatigue—Betamethasone—psoriatic arthritis	0.000513	0.00226	CcSEcCtD
Isoniazid—Fatigue—Dexamethasone—psoriatic arthritis	0.000513	0.00226	CcSEcCtD
Isoniazid—Anorexia—Prednisone—psoriatic arthritis	0.000494	0.00218	CcSEcCtD
Isoniazid—Ill-defined disorder—Methotrexate—psoriatic arthritis	0.000492	0.00217	CcSEcCtD
Isoniazid—Feeling abnormal—Dexamethasone—psoriatic arthritis	0.00049	0.00216	CcSEcCtD
Isoniazid—Feeling abnormal—Betamethasone—psoriatic arthritis	0.00049	0.00216	CcSEcCtD
Isoniazid—Hypersensitivity—Triamcinolone—psoriatic arthritis	0.000483	0.00213	CcSEcCtD
Isoniazid—Hypersensitivity—Methylprednisolone—psoriatic arthritis	0.000482	0.00213	CcSEcCtD
Isoniazid—Malaise—Methotrexate—psoriatic arthritis	0.000478	0.00211	CcSEcCtD
Isoniazid—Asthenia—Triamcinolone—psoriatic arthritis	0.00047	0.00207	CcSEcCtD
Isoniazid—Body temperature increased—Betamethasone—psoriatic arthritis	0.00047	0.00207	CcSEcCtD
Isoniazid—Body temperature increased—Dexamethasone—psoriatic arthritis	0.00047	0.00207	CcSEcCtD
Isoniazid—Asthenia—Methylprednisolone—psoriatic arthritis	0.000469	0.00207	CcSEcCtD
Isoniazid—Paraesthesia—Prednisone—psoriatic arthritis	0.000465	0.00205	CcSEcCtD
Isoniazid—Convulsion—Methotrexate—psoriatic arthritis	0.00046	0.00203	CcSEcCtD
Isoniazid—Dyspepsia—Prednisone—psoriatic arthritis	0.000456	0.00201	CcSEcCtD
Isoniazid—Decreased appetite—Prednisone—psoriatic arthritis	0.00045	0.00199	CcSEcCtD
Isoniazid—Rash—Prednisolone—psoriatic arthritis	0.000449	0.00198	CcSEcCtD
Isoniazid—Fatigue—Prednisone—psoriatic arthritis	0.000447	0.00197	CcSEcCtD
Isoniazid—Discomfort—Methotrexate—psoriatic arthritis	0.000446	0.00197	CcSEcCtD
Isoniazid—Feeling abnormal—Prednisone—psoriatic arthritis	0.000427	0.00188	CcSEcCtD
Isoniazid—Asthenia—Betamethasone—psoriatic arthritis	0.000427	0.00188	CcSEcCtD
Isoniazid—Asthenia—Dexamethasone—psoriatic arthritis	0.000427	0.00188	CcSEcCtD
Isoniazid—Thrombocytopenia—Methotrexate—psoriatic arthritis	0.000424	0.00187	CcSEcCtD
Isoniazid—Nausea—Prednisolone—psoriatic arthritis	0.000423	0.00187	CcSEcCtD
Isoniazid—Vomiting—Triamcinolone—psoriatic arthritis	0.000417	0.00184	CcSEcCtD
Isoniazid—Vomiting—Methylprednisolone—psoriatic arthritis	0.000416	0.00183	CcSEcCtD
Isoniazid—Rash—Triamcinolone—psoriatic arthritis	0.000413	0.00182	CcSEcCtD
Isoniazid—Anorexia—Methotrexate—psoriatic arthritis	0.000413	0.00182	CcSEcCtD
Isoniazid—Rash—Methylprednisolone—psoriatic arthritis	0.000412	0.00182	CcSEcCtD
Isoniazid—Body temperature increased—Prednisone—psoriatic arthritis	0.000409	0.00181	CcSEcCtD
Isoniazid—Nausea—Triamcinolone—psoriatic arthritis	0.000389	0.00172	CcSEcCtD
Isoniazid—Paraesthesia—Methotrexate—psoriatic arthritis	0.000389	0.00171	CcSEcCtD
Isoniazid—Nausea—Methylprednisolone—psoriatic arthritis	0.000388	0.00171	CcSEcCtD
Isoniazid—Hypersensitivity—Prednisone—psoriatic arthritis	0.000382	0.00168	CcSEcCtD
Isoniazid—Dyspepsia—Methotrexate—psoriatic arthritis	0.000381	0.00168	CcSEcCtD
Isoniazid—Vomiting—Dexamethasone—psoriatic arthritis	0.000378	0.00167	CcSEcCtD
Isoniazid—Vomiting—Betamethasone—psoriatic arthritis	0.000378	0.00167	CcSEcCtD
Isoniazid—Decreased appetite—Methotrexate—psoriatic arthritis	0.000376	0.00166	CcSEcCtD
Isoniazid—Rash—Betamethasone—psoriatic arthritis	0.000375	0.00165	CcSEcCtD
Isoniazid—Rash—Dexamethasone—psoriatic arthritis	0.000375	0.00165	CcSEcCtD
Isoniazid—Gastrointestinal disorder—Methotrexate—psoriatic arthritis	0.000374	0.00165	CcSEcCtD
Isoniazid—Fatigue—Methotrexate—psoriatic arthritis	0.000373	0.00165	CcSEcCtD
Isoniazid—Asthenia—Prednisone—psoriatic arthritis	0.000372	0.00164	CcSEcCtD
Isoniazid—Feeling abnormal—Methotrexate—psoriatic arthritis	0.000357	0.00157	CcSEcCtD
Isoniazid—Nausea—Betamethasone—psoriatic arthritis	0.000353	0.00156	CcSEcCtD
Isoniazid—Nausea—Dexamethasone—psoriatic arthritis	0.000353	0.00156	CcSEcCtD
Isoniazid—Body temperature increased—Methotrexate—psoriatic arthritis	0.000342	0.00151	CcSEcCtD
Isoniazid—Vomiting—Prednisone—psoriatic arthritis	0.000329	0.00145	CcSEcCtD
Isoniazid—Rash—Prednisone—psoriatic arthritis	0.000327	0.00144	CcSEcCtD
Isoniazid—Hypersensitivity—Methotrexate—psoriatic arthritis	0.000319	0.00141	CcSEcCtD
Isoniazid—Asthenia—Methotrexate—psoriatic arthritis	0.000311	0.00137	CcSEcCtD
Isoniazid—Nausea—Prednisone—psoriatic arthritis	0.000308	0.00136	CcSEcCtD
Isoniazid—Vomiting—Methotrexate—psoriatic arthritis	0.000275	0.00121	CcSEcCtD
Isoniazid—Rash—Methotrexate—psoriatic arthritis	0.000273	0.0012	CcSEcCtD
Isoniazid—Nausea—Methotrexate—psoriatic arthritis	0.000257	0.00113	CcSEcCtD
